Reassessing blood product irradiation in haploidentical transplantation: a single-center perspective
These findings support leukoreduction as a primary TA-GVHD preventive measure,along with the advantage in cost reduction.
Authors
- David Gómez‐Almaguer (ORCID: https://orcid.org/0000-0002-0460-6427)
- Olga Graciela Cantú‐Rodríguez (ORCID: https://orcid.org/0000-0003-2134-3734)
- Andrés Gómez‐De León (ORCID: https://orcid.org/0000-0001-6904-9345)
- Rosario Salazar‐Riojas (ORCID: https://orcid.org/0000-0002-3213-5810)
- José Carlos Jaime‐Pérez (ORCID: https://orcid.org/0000-0001-6804-9095)
- Perla R. Colunga‐Pedraza (ORCID: https://orcid.org/0000-0002-9937-439X)
- Cesar Homero Gutiérrez‐Aguirre (ORCID: https://orcid.org/0000-0002-9876-3633)
- Dalila Marisol Alvarado Navarro
- Juan P. Martínez-Hernández (ORCID: https://orcid.org/0009-0000-6175-1930)
- Yair Omar Chávez-Estrada (ORCID: https://orcid.org/0000-0002-8418-7655)
- Ana Karen Hernández-Navarro
- Yesica A. López-Mora (ORCID: https://orcid.org/0009-0006-1819-7931)
Institutions
- Universidad Autónoma de Nuevo León (MX)
Publication Details
- Journal
- Hematology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1080/16078454.2024.2420144
- Citations
- 2
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.15